InvestorsHub Logo
Followers 29
Posts 2503
Boards Moderated 0
Alias Born 04/09/2010

Re: None

Thursday, 10/29/2015 2:11:14 PM

Thursday, October 29, 2015 2:11:14 PM

Post# of 4126
Something Adam F didn't include in any of his articles about Firdapse.

"Catalyst’s Firdapse contains the phosphate salt of 3,4-DAP. The phosphate salt form is more stable than the free base form of the 3,4-DAP that is available from Jacobus. Catalyst CEO Patrick McEnany stressed that their 3,4-DAP is produced under all requirements of cGMP. If there were an approved drug by the FDA, most patients would have easy access to this drug."

Also this about Jacobus: "Even more serious is the cGMP defects of Jacobus in the past. The FDA issued 483 inspection reports for the Jacobus facility in 2011 and again in 2012 (read them here and here)."
http://bit.ly/1jUJK1M
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CPRX News